262 related articles for article (PubMed ID: 28049260)
1. A prospective study of nutritional supplementation for preventing oral mucositis in cancer patients receiving chemotherapy.
Okada T; Nakajima Y; Nishikage T; Ryotokuji T; Miyawaki Y; Hoshino A; Tokairin Y; Kawada K; Nagai K; Kawano T
Asia Pac J Clin Nutr; 2017 Jan; 26(1):42-48. PubMed ID: 28049260
[TBL] [Abstract][Full Text] [Related]
2. [Elental prevented and reduced oral mucositis during chemotherapy in patients esophageal cancer].
Fukui T; Itoh Y; Orihara M; Yoshizawa K; Takeda H; Kawada S; Yoshioka T
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2597-601. PubMed ID: 22189225
[TBL] [Abstract][Full Text] [Related]
3. A prospective pilot study of an elemental nutritional supplement for prevention of oral mucositis during S-1 adjuvant chemotherapy for gastric cancer.
Toyomasu Y; Mochiki E; Yanai M; Suzuki M; Yanoma T; Kimura A; Kogure N; Ogata K; Kuwano H
Surg Oncol; 2019 Jun; 29():97-101. PubMed ID: 31196501
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
Harada K; Ferdous T; Horinaga D; Uchida K; Mano T; Mishima K; Park S; Hanazawa H; Takahashi S; Okita A; Fukunaga M; Maruta J; Kami N; Shibuya K; Ueyama Y
Support Care Cancer; 2016 Feb; 24(2):953-959. PubMed ID: 26248650
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of amino-acid-rich elemental diet Elental® on chemotherapy-induced oral mucositis in patients with colorectal cancer: a prospective pilot study.
Ogata Y; Ishibashi N; Yamaguchi K; Uchida S; Kamei H; Nakayama G; Hirakawa H; Tanigawa M; Akagi Y
Support Care Cancer; 2016 Feb; 24(2):783-789. PubMed ID: 26266658
[TBL] [Abstract][Full Text] [Related]
6. The amino acid-rich elemental diet Elental® preserves lean body mass during chemo- or chemoradiotherapy for esophageal cancer.
Ishikawa T; Yasuda T; Doi T; Okayama T; Sakamoto N; Gen Y; Dohi O; Yoshida N; Kamada K; Uchiyama K; Handa O; Takagi T; Konishi H; Yagi N; Kokura S; Naito Y; Itoh Y
Oncol Rep; 2016 Aug; 36(2):1093-100. PubMed ID: 27374272
[TBL] [Abstract][Full Text] [Related]
7. Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy: a feasibility study.
Tanaka Y; Takahashi T; Yamaguchi K; Osada S; Shimokawa T; Yoshida K
Support Care Cancer; 2016 Feb; 24(2):933-941. PubMed ID: 26266659
[TBL] [Abstract][Full Text] [Related]
8. The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study).
Tanaka Y; Ueno T; Yoshida N; Akutsu Y; Takeuchi H; Baba H; Matsubara H; Kitagawa Y; Yoshida K
Esophagus; 2018 Oct; 15(4):239-248. PubMed ID: 30225745
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of Elental on prevention for chemotherapy-induced oral mucositis in colorectal cancer patients].
Ogata Y; Takeuchi M; Ishibashi N; Kibe S; Takahashi K; Uchida S; Murakami N; Yahara T; Shirouzu K
Gan To Kagaku Ryoho; 2012 Apr; 39(4):583-7. PubMed ID: 22504682
[TBL] [Abstract][Full Text] [Related]
10. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
[TBL] [Abstract][Full Text] [Related]
11. Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5).
Tanaka Y; Takeuchi H; Nakashima Y; Nagano H; Ueno T; Tomizuka K; Morita S; Emi Y; Hamai Y; Hihara J; Saeki H; Oki E; Kunisaki C; Otsuji E; Baba H; Matsubara H; Maehara Y; Kitagawa Y; Yoshida K
ESMO Open; 2021 Oct; 6(5):100277. PubMed ID: 34626918
[TBL] [Abstract][Full Text] [Related]
12. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
[TBL] [Abstract][Full Text] [Related]
13. Oral cryotherapy for prophylaxis of oral mucositis caused by docetaxel, cisplatin, and fluorouracil chemotherapy for esophageal cancer.
Okamoto K; Ninomiya I; Yamaguchi T; Terai S; Nakanuma S; Kinoshita J; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Esophagus; 2019 Apr; 16(2):207-213. PubMed ID: 30600487
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of elemental diets to prevent oral mucositis associated with cancer therapy: A meta-analysis.
Tanaka Y; Shimokawa T; Harada K; Yoshida K
Clin Nutr ESPEN; 2022 Jun; 49():172-180. PubMed ID: 35623809
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy - a randomized controlled trial.
Katrancı N; Ovayolu N; Ovayolu O; Sevinc A
Eur J Oncol Nurs; 2012 Sep; 16(4):339-44. PubMed ID: 21911313
[TBL] [Abstract][Full Text] [Related]
16. Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil.
Nikoletti S; Hyde S; Shaw T; Myers H; Kristjanson LJ
J Clin Nurs; 2005 Jul; 14(6):750-3. PubMed ID: 15946283
[TBL] [Abstract][Full Text] [Related]
17. Elemental Diet Accelerates the Recovery From Oral Mucositis and Dermatitis Induced by 5-Fluorouracil Through the Induction of Fibroblast Growth Factor 2.
Harada K; Ferdous T; Kobayashi H; Ueyama Y
Integr Cancer Ther; 2018 Jun; 17(2):423-430. PubMed ID: 28745083
[TBL] [Abstract][Full Text] [Related]
18. Laser Therapy as a Preventive Approach for Oral Mucositis in Cancer Patients Undergoing Chemotherapy: The Potential Role of Superoxide Dismutase.
Menezes BC; Thebit MM; Bonela LAS; Oliveira KG; Gonçalves WL; Bissoli NS; Sartorio CL; Gouvea SA
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3211-3217. PubMed ID: 34710997
[TBL] [Abstract][Full Text] [Related]
19. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy: the effect of oral cryotherapy on the development of mucositis.
Karagözoğlu S; Filiz Ulusoy M
J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
